For the patient sitting in a dentist's chair waiting on a crown, the standard of care has not changed much in a generation. The dentist takes an impression, ships a physical mold to an independent dental lab, and the patient goes home with a temporary restoration for two to three weeks while a technician somewhere in the country fabricates the permanent piece by hand. The fit is often imperfect. Remakes are common. The patient comes back for another appointment, sometimes two.
For the roughly 15 million Americans who get a crown, bridge, denture, or clear aligner each year, the experience is defined less by clinical innovation than by logistics friction.
Dandy, the New York-based dental technology company founded in 2018 by Toni Oloko and Daniel Hanover, is trying to compress that workflow into something closer to a same-week digital process. The company sells dentists an end-to-end system that pairs intraoral scanners and software with its own manufacturing footprint, then routes restorations like veneers, dentures, crowns, and aligners through a network of labs to find the fastest turnaround and lowest price [Forbes]. The pitch to the practice is straightforward: less chair time per patient, fewer remakes, and a single vendor relationship instead of a tangle of lab invoices.
The bet
Dandy's wedge is the scanner and the software that sits on top of it. Once a dentist is capturing digital impressions on Dandy's stack, the lab order, the case design, and the manufacturing handoff all flow through the company's system [Crunchbase]. That is a meaningful change from the legacy model, where the lab is a separate business with its own software, its own turnaround clock, and its own quality control. By owning both the digital intake and the production decision, Dandy positions itself as the operating layer for a category that has historically been fragmented across thousands of independent labs.
The company says it serves 4,000 dentists across the United States [Forbes] and surpassed $100 million in revenue within its first two years of operation [Dandy]. A separate third-party database lists annual revenue at $175.5 million [RocketReach]. Headcount figures vary by source, with Forbes citing 700 employees [Forbes] and RocketReach listing 1,091 [RocketReach], a spread that reflects how quickly the company has been hiring against its manufacturing buildout.
Why it could be big
The global dental industry is roughly a $400 billion market [Crunchbase], and the lab segment inside it has been one of the slowest corners of healthcare to digitize. Independent labs still dominate, intraoral scanner penetration in US general practices remains well under half by most industry estimates, and consolidation has been gradual rather than sweeping. A company that can put a scanner in the operatory, capture the case digitally, and own the manufacturing route has a credible path to becoming the default infrastructure for restorative dentistry in North America.
The investor syndicate reflects that thesis. Dandy's Series C was led by Human Capital, with prior backing from General Catalyst, Inspired Capital, and Dorm Room Fund [Crunchbase]. Inspired Capital, founded by Alexa von Tobel, has publicly grouped Dandy among the portfolio bets it considers candidates for outsized outcomes [Forbes, March 2024]. General Catalyst's involvement matters too: the firm has been an active thesis investor in healthcare delivery infrastructure, and Dandy fits the pattern of a category-defining vertical software company with real physical operations underneath.
| Metric | Value |
|---|---|
| Dentists served | 4000 practices |
| Employees (Forbes) | 700 people |
| Employees (RocketReach) | 1091 people |
| Annual revenue | 175 $M |
| First two-year revenue | 100 $M |
The team and traction
Oloko and Hanover met at the University of Pennsylvania and originally piloted the business under the brand Orthly in 2019 before relaunching as Dandy [PhillyMag, 2019] [Forbes]. Both founders were named to the Forbes 30 Under 30 Enterprise Technology list for 2023 [Forbes, November 2022]. The company is still actively hiring against the next phase, including a Director of Product and Innovation Marketing role posted recently [AshbyHQ], which suggests the go-to-market motion is broadening from direct sales into category positioning.
The honest counterfactual
What skeptics will point to is the competitive shape of the market. Glidewell, the largest independent dental lab in the United States, has decades of relationships with practices and its own digital workflow. ClearCorrect, owned by Straumann, competes directly in clear aligners, and the collapse of SmileDirectClub in 2023 demonstrated how unforgiving the consumer-adjacent end of dentistry can be when unit economics drift. Dandy is not a direct-to-consumer business, which is the most important distinction: its customer is the dentist, and the regulatory and clinical accountability stays with the licensed provider. The company's answer to lab-network competition is vertical integration of the software and manufacturing layers, which Glidewell historically has not offered as a single bundled product to the practice [Crunchbase]. Whether that integration translates into durable margin advantage as Dandy scales its own production footprint is the open question, and it is the one the next funding round will likely be priced on.
What to watch
The twelve-month watch list is concrete. First, whether Dandy can keep its remake rates and turnaround times tight as case volume grows: in dentistry, clinical reputation among practitioners spreads through professional networks faster than any marketing spend can keep up with. Second, whether the company expands beyond restorations and aligners into adjacent categories like implants, where margins are higher and the digital workflow is similarly underbuilt. Third, the next financing event, which will reveal how public markets and late-stage investors are valuing vertically integrated healthcare infrastructure after a cautious 2024 for the category.
For the patient, none of this will feel like a revolution on the day it happens. It will feel like a crown that fits the first time, delivered in a week instead of three. That is the outcome Dandy is selling, and on the evidence so far, dentists are buying.
Pulse Raman, Health and Bio Correspondent, Startuply.